Related Experiment Video

Updated: Aug 10, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Mitogen requirement for cell cycle progression in the absence of pocket protein activity

Floris Foijer1, Rob M F Wolthuis, Valerie Doodeman

  • 1Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Cancer Cell
|December 13, 2005
PubMed

Insights

Mouse cells lacking retinoblastoma proteins (TKO MEFs) lose the G1 restriction point. Surviving cells arrest in G2, revealing a new cell cycle checkpoint involving p53, crucial for preventing uncontrolled cell growth.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Retinoblastoma proteins (Rb) are critical cell cycle regulators.
  • Loss of Rb function removes the G1 restriction point, impacting cell proliferation.
  • Mitogen deprivation typically induces apoptosis in Rb-deficient cells.

Purpose of the Study:

  • To investigate the cell cycle behavior of Rb-deficient cells under mitogen deprivation.
  • To identify the mechanisms underlying cell cycle arrest in these cells.
  • To explore the role of p53 in regulating cell cycle progression in the absence of Rb.

Main Methods:

  • Utilized TKO MEFs (triple knockout for Rb family members).
  • Subjected cells to serum depletion and subsequent restimulation.
  • Analyzed cell cycle progression and protein complex formation (e.g., cyclin-cdk).

Main Results:

  • TKO MEFs that survive serum depletion pass G1 but arrest in G2.
  • p21CIP1 and p27KIP1 inhibit Cyclin A-Cdk2 and sequester Cyclin B1-Cdk1.
  • Mitogen restimulation or p53 inactivation alleviates the G2 arrest.

Conclusions:

  • Disclosed a novel G2 cell cycle arrest mechanism in mitogen-deprived cells lacking Rb.
  • This G2 arrest restricts proliferation in cells that have lost the G1 checkpoint.
  • p53's involvement explains the synergy between Rb and p53 loss in tumorigenesis.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...